These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22672269

  • 21. Anticoagulant properties in vitro of heparan sulphates.
    Hubbard AR, Jennings CA, Barrowcliffe TW.
    Thromb Res; 1984 Sep 01; 35(5):567-76. PubMed ID: 6237461
    [Abstract] [Full Text] [Related]

  • 22. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM, Capillé NV, Santos GR, Vairo BC, Oliveira SN, Fonseca RJ, Mourão PA.
    Thromb Haemost; 2012 May 01; 107(5):903-15. PubMed ID: 22437650
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Isolation and characterization of heparin from tuna skins.
    Jeske WP, McDonald MK, Hoppensteadt DA, Bau EC, Mendes A, Dietrich CP, Walenga JM, Coyne E.
    Clin Appl Thromb Hemost; 2007 Apr 01; 13(2):137-45. PubMed ID: 17456622
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW, Lee IS, Sim JS, Toida T, Linhardt RJ, Kim YS.
    Thromb Res; 2004 Apr 01; 113(1):67-73. PubMed ID: 15081567
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW, Strebus AF, Meinders AE, Briët E.
    Haemostasis; 1996 Apr 01; 26(2):85-9. PubMed ID: 9119287
    [Abstract] [Full Text] [Related]

  • 30. Absorption and tissue distribution of a novel carboxymethyldextran after oral administration.
    Charef S, Papy-Garcia D, Courty J.
    Biomed Pharmacother; 2010 Nov 01; 64(9):627-32. PubMed ID: 20888180
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos CK, Perry D, Burroughs AK.
    Blood Coagul Fibrinolysis; 2007 Apr 01; 18(3):227-36. PubMed ID: 17413758
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma.
    Wages DS, Staprans I, Hambleton J, Bass NM, Corash L.
    Am J Hematol; 1998 Aug 01; 58(4):285-92. PubMed ID: 9692391
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland.
    Ledoux D, Caruelle D, Sabourin JC, Liu J, Crepin M, Barritault D, Courty J.
    J Histochem Cytochem; 1997 Sep 01; 45(9):1239-45. PubMed ID: 9283611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.